Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 2
1969 2
1971 1
1974 3
1978 1
1980 5
1981 4
1982 2
1983 1
1984 4
1985 2
1986 3
1987 2
1988 4
1989 2
1990 3
1991 7
1992 4
1993 10
1994 8
1995 8
1996 4
1997 8
1998 3
1999 5
2000 10
2001 8
2002 9
2003 5
2004 7
2005 3
2006 10
2007 8
2008 11
2009 12
2010 14
2011 24
2012 25
2013 25
2014 31
2015 37
2016 32
2017 42
2018 34
2019 38
2020 67
2021 103
2022 69
2023 77
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Results by year

Filters applied: . Clear all
Page 1
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer.
Lasorsa F, di Meo NA, Rutigliano M, Ferro M, Terracciano D, Tataru OS, Battaglia M, Ditonno P, Lucarelli G. Lasorsa F, et al. Among authors: ferro m. Int J Mol Sci. 2023 Jan 4;24(2):910. doi: 10.3390/ijms24020910. Int J Mol Sci. 2023. PMID: 36674430 Free PMC article. Review.
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.
Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, Autorino R, Battaglia M, Ditonno P, Lucarelli G. Lasorsa F, et al. Among authors: ferro m. Int J Mol Sci. 2023 Aug 24;24(17):13179. doi: 10.3390/ijms241713179. Int J Mol Sci. 2023. PMID: 37685983 Free PMC article. Review.
Radiomics in prostate cancer: an up-to-date review.
Ferro M, de Cobelli O, Musi G, Del Giudice F, Carrieri G, Busetto GM, Falagario UG, Sciarra A, Maggi M, Crocetto F, Barone B, Caputo VF, Marchioni M, Lucarelli G, Imbimbo C, Mistretta FA, Luzzago S, Vartolomei MD, Cormio L, Autorino R, Tătaru OS. Ferro M, et al. Ther Adv Urol. 2022 Jul 4;14:17562872221109020. doi: 10.1177/17562872221109020. eCollection 2022 Jan-Dec. Ther Adv Urol. 2022. PMID: 35814914 Free PMC article. Review.
Progress in prostate cancer prevention.
Cozzi G, Musi G, Ferro M, Cioffi A, de Cobelli O, Corso G. Cozzi G, et al. Among authors: ferro m. Eur J Cancer Prev. 2022 Nov 1;31(6):554-557. doi: 10.1097/CEJ.0000000000000745. Epub 2022 Mar 29. Eur J Cancer Prev. 2022. PMID: 35352690
MRI and Active Surveillance for Prostate Cancer.
Porreca A, Colicchia M, Busetto GM, Ferro M. Porreca A, et al. Among authors: ferro m. Diagnostics (Basel). 2020 Aug 14;10(8):590. doi: 10.3390/diagnostics10080590. Diagnostics (Basel). 2020. PMID: 32823810 Free PMC article.
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A, Cilio S, Contieri R, Spena G, Napolitano L, Manfredi C, Franco A, Crocerossa F, Cerrato C, Ferro M, Del Giudice F, Verze P, Lasorsa F, Salonia A, Nair R, Walz J, Lucarelli G, Pandolfo SD. Aveta A, et al. Among authors: ferro m. Int J Mol Sci. 2023 Jun 29;24(13):10846. doi: 10.3390/ijms241310846. Int J Mol Sci. 2023. PMID: 37446024 Free PMC article. Review.
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.
Ferro M, Crocetto F, Barone B, Del Giudice F, Maggi M, Lucarelli G, Busetto GM, Autorino R, Marchioni M, Cantiello F, Crocerossa F, Luzzago S, Piccinelli M, Mistretta FA, Tozzi M, Schips L, Falagario UG, Veccia A, Vartolomei MD, Musi G, de Cobelli O, Montanari E, Tătaru OS. Ferro M, et al. Ther Adv Urol. 2023 Apr 17;15:17562872231164803. doi: 10.1177/17562872231164803. eCollection 2023 Jan-Dec. Ther Adv Urol. 2023. PMID: 37113657 Free PMC article. Review.
721 results